Evidence map

ArticleRheumatology and therapy2024

Does Concomitant Use of Methotrexate with JAK Inhibition Confer Benefit for Cardiovascular Outcomes? A Commentary.

Peter C Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39397239